


Searching News Database: Hadasit
HSMN NewsFeed - 16 Jun 2021
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
HSMN NewsFeed - 27 Aug 2007
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
Additional items found! 2
Members Archive contains
2 additional stories matching:
Hadasit
(Password required)
Hadasit
(Password required)
